Tradestie Institutional Equity Comparison Engine

EVGN vs KMDA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KMDA Overall Edge

KMDA Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kamada Ltd (KMDA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EVGN trades at N/M Forward P/E with -858.2% operating margin (-60.7% YoY revenue) versus KMDA at 14.1x Forward P/E and 15.4% operating margin (+10.7% YoY). In options structure, EVGN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against KMDA sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner KMDA
EVGN N/M vs KMDA 14.1x Fwd P/E
Growth & Margin Winner KMDA
Op Margin -858.2% vs 15.4% ยท YoY -60.7% vs +10.7%
Momentum & Technical Winner KMDA
1Y -71.9% vs +16.7% ยท 52W Pos 9% vs 57%
Options & Structure Winner KMDA
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (50th %ile IV)
EVGN NASDAQ
Evogene Ltd.
Agricultural Chemicals
$0.34
-13.17% 1D
Market Cap $6.0M
1M Return -7.58%
1Y Return -71.89%
Forward P/E N/M
Unified AI Score
44.1 / 100 HOLD
Tech 42.0 Fund 44.0 Flow 50.0 Mom 60.0
KMDA NASDAQ
Kamada Ltd
Pharmaceutical Preparations
$8.16
+0.62% 1D
Market Cap $468.2M
1M Return +7.23%
1Y Return +16.74%
Forward P/E 14.1x
Unified AI Score
42.7 / 100 HOLD
Tech 28.0 Fund 46.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EVGN -71.89% KMDA +16.74% Spread: +88.63 pp (KMDA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EVGN TTM Op. Margin: -858.2% KMDA TTM Op. Margin: 15.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVGN vs KMDA. Trailing 12-month operating profitability (EVGN -858.2% vs KMDA 15.4%) and valuation multiples (EVGN N/M vs KMDA 14.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EVGN (1) vs KMDA (9)
Institutional Metric EVGN KMDA Criterion Row Winner
Market Capitalization Scale $6.0M $468.2M Larger Scale KMDA
Trailing P/E Ratio Valuation N/M 21.3x Lower Multiple KMDA
Forward P/E Ratio Valuation N/M 14.1x Lower Multiple KMDA
Revenue Growth (YoY) Growth -60.7% +10.7% Higher Growth KMDA
Operating Margin (TTM) Profitability -858.2% 15.4% Higher Margin KMDA
Net Profit Margin Profitability 0.0% 12.7% Higher Margin KMDA
Return on Equity (ROE) Capital Efficiency -182.8% 9.3% Higher ROE KMDA
52-Week Range Position Momentum 9% ($0โ€“$1) 57% ($7โ€“$9) Stronger Trend KMDA
Beta / 30D Volatility Risk Regime 1.37ฮฒ ยท 138% Vol 0.96ฮฒ ยท 50% Vol Lower Realized Risk KMDA
Unified Institutional Score Composite Signal 44.1 / 100 (HOLD) 42.7 / 100 (HOLD) Higher Composite EVGN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EVGN vs KMDA Buy Guide
EVGN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EVGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
KMDA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live KMDA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EVGN nor KMDA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.